These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. The intracellular 52-kd Ro/SSA autoantigen in keratinocytes is up-regulated by tumor necrosis factor alpha via tumor necrosis factor receptor I. Gerl V; Hostmann B; Johnen C; Waka A; Gerl M; Schumann F; Klein R; Radbruch A; Hiepe F Arthritis Rheum; 2005 Feb; 52(2):531-8. PubMed ID: 15692985 [TBL] [Abstract][Full Text] [Related]
26. Anti-Ro/SSA and La/SSB antibodies. Franceschini F; Cavazzana I Autoimmunity; 2005 Feb; 38(1):55-63. PubMed ID: 15804706 [TBL] [Abstract][Full Text] [Related]
27. Cutaneous characteristics and association with antinuclear antibodies in 402 patients with different subtypes of lupus erythematosus. Patsinakidis N; Gambichler T; Lahner N; Moellenhoff K; Kreuter A J Eur Acad Dermatol Venereol; 2016 Dec; 30(12):2097-2104. PubMed ID: 27431977 [TBL] [Abstract][Full Text] [Related]
28. The autoantibody response to Ro/SSA in cutaneous lupus erythematosus. Lee LA; Roberts CM; Frank MB; McCubbin VR; Reichlin M Arch Dermatol; 1994 Oct; 130(10):1262-8. PubMed ID: 7944507 [TBL] [Abstract][Full Text] [Related]
29. Anti-La negative cutaneous lupus erythematosus in a newborn. Sarkar M; Ghosh JK; Sinha MK; Chatterjee S Indian J Pediatr; 2009 Jun; 76(6):649-50. PubMed ID: 19618147 [TBL] [Abstract][Full Text] [Related]
30. Ethnic differences in immunogenetic features and photosensitivity of cutaneous lupus erythematosus. Furukawa F; Muto M Arch Dermatol Res; 2009 Jan; 301(1):111-5. PubMed ID: 18797890 [TBL] [Abstract][Full Text] [Related]
31. A characteristic cutaneous direct immunofluorescent pattern associated with Ro(SS-A) antibodies in subacute cutaneous lupus erythematosus. Valeski JE; Kumar V; Forman AB; Beutner EH; Chorzelski TP J Am Acad Dermatol; 1992 Aug; 27(2 Pt 1):194-8. PubMed ID: 1430355 [TBL] [Abstract][Full Text] [Related]
32. Subacute cutaneous lupus erythematosus--clinical, histopathological and immunophenotypical study of five cases. Vázquez-Doval J; Ruiz de Erenchun F; Sánchez-Ibarrola A; Contreras F; Soto de Delás J; Quintanilla E J Investig Allergol Clin Immunol; 1992; 2(1):27-32. PubMed ID: 1342879 [TBL] [Abstract][Full Text] [Related]
33. A monoclonal Ro-antibody and the serum of a Ro-positive patient with subacute cutaneous lupus erythematosus (SCLE) react with basal layers of human epidermis. Mayet WJ; Bachmann M; Pfeifer K; Schröder HC; Müller WE; Gudat W; Korting GW; Meyer zum Büschenfelde KH Eur J Clin Invest; 1988 Oct; 18(5):465-71. PubMed ID: 3147897 [TBL] [Abstract][Full Text] [Related]
34. Questions pertaining to the true frequencies with which anti-Ro/SS-A autoantibody and the HLA-DR3 phenotype occur in subacute cutaneous lupus erythematosus patients. Sontheimer RD J Am Acad Dermatol; 1987 Jan; 16(1 Pt 1):130-4. PubMed ID: 3492520 [No Abstract] [Full Text] [Related]
35. [Cytotoxic effect on human keratinocytes caused by anti-Ro-(SS-A) antibodies and UVA in vitro]. Brink I; Böhm F; Meffert H; Sönnichsen N Dermatol Monatsschr; 1990; 176(11):701-6. PubMed ID: 2083611 [TBL] [Abstract][Full Text] [Related]
36. Neonatal lupus and the pathogenesis of cutaneous lupus. Lee LA; Norris DA; Weston WL Pediatr Dermatol; 1986 Dec; 3(6):491-7. PubMed ID: 3494240 [No Abstract] [Full Text] [Related]